![](/images/graphics-bg.png)
Development of Immunopathogenesis Strategies to Treat Behçet’s Disease
Author
Source
Pathology Research International
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-04-03
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Behçet disease is a chronic relapsing vasculitis with unclear etiology and immunopathogenesis.
Antigenic stimuli, antigen presenting cells, T cells, monocyte, and neutrophil and endothelial cells are major parts of the pathology of the disease.
Understanding of the new pathogenic mechanisms based on molecular structure of the disease helps us in improving the novel therapeutic modalities.
These drugs target specific and nonspecific inhibition of the immun system.
These therapies include biologic agents, new topical and systemic immunosuppressants, tolerizing agents, and immunoablation.
Novel treatment will be promising to treat the especially recalcitrant cases to conventional therapy.
In this paper, new aspect of the immunopathogenesis of Behçet’s diseases and novel treatment modalities will be discussed.
American Psychological Association (APA)
Köse, Osman. 2012. Development of Immunopathogenesis Strategies to Treat Behçet’s Disease. Pathology Research International،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-458424
Modern Language Association (MLA)
Köse, Osman. Development of Immunopathogenesis Strategies to Treat Behçet’s Disease. Pathology Research International No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-458424
American Medical Association (AMA)
Köse, Osman. Development of Immunopathogenesis Strategies to Treat Behçet’s Disease. Pathology Research International. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-458424
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-458424